- Report
- October 2023
- 173 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- October 2023
- 181 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- October 2023
- 171 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- October 2023
- 133 Pages
North America
From €3790EUR$4,000USD£3,199GBP
- Report
- October 2023
- 128 Pages
North America
From €3790EUR$4,000USD£3,199GBP
- Report
- October 2023
- 180 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- January 2023
- 77 Pages
United Kingdom
From €3317EUR$3,500USD£2,799GBP
- Report
- December 2023
- 139 Pages
Global
From €4217EUR$4,450USD£3,559GBP
- Report
- August 2022
- 30 Pages
Global
From €3080EUR$3,250USD£2,599GBP
- Report
- July 2023
- 117 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- March 2024
- 174 Pages
Global
From €7107EUR$7,500USD£5,998GBP
- Report
- February 2024
- 200 Pages
Global
From €7107EUR$7,500USD£5,998GBP
- Report
- November 2023
- 30 Pages
Global
From €3080EUR$3,250USD£2,599GBP
- Report
- May 2023
- 200 Pages
Global
From €7107EUR$7,500USD£5,998GBP
- Drug Pipelines
- January 2023
- 30 Pages
United States
From €3080EUR$3,250USD£2,599GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €3080EUR$3,250USD£2,599GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €3080EUR$3,250USD£2,599GBP
- Drug Pipelines
- September 2022
- 30 Pages
Global
From €3080EUR$3,250USD£2,599GBP
- Report
- February 2024
- 112 Pages
Global
From €4501EUR$4,750USD£3,799GBP
- Report
- April 2023
- 100 Pages
Global
From €4501EUR$4,750USD£3,799GBP

The Targeted Therapies market within the context of Genomics is focused on the development of treatments that target specific genetic mutations or pathways. These therapies are designed to be more effective and have fewer side effects than traditional treatments. Genomics has enabled the development of personalized treatments that are tailored to the individual patient's genetic makeup. This has allowed for the development of drugs that target specific mutations or pathways, leading to more effective treatments.
The Targeted Therapies market is a rapidly growing field, with many companies investing in research and development. Companies such as Gilead Sciences, Novartis, and AstraZeneca are leading the way in the development of targeted therapies. Other companies such as Merck, Pfizer, and Roche are also investing in the development of targeted therapies. Show Less Read more